Jeito Capital logo

Jeito Capital

Europe, Ile-de-France, France, Paris

Description

Jeito Capital is a global investment company that invests in companies in the field of medical innovation.

Investor Profile

Jeito Capital has made 27 investments, with 7 in the past 12 months and 67% as lead.

Stage Focus

  • Series A (37%)
  • Series B (33%)
  • Series C (19%)
  • Series D (7%)
  • Series Unknown (4%)

Country Focus

  • United States (26%)
  • Switzerland (22%)
  • France (15%)
  • United Kingdom (11%)
  • Belgium (7%)
  • Germany (7%)
  • Denmark (7%)
  • The Netherlands (4%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
  • Medical Device
  • Product Research
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jeito Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 5
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 5
UPMC Enterprises
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 4
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 5
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 7
Pureos Bioventures
Europe, Zurich, Switzerland, Küsnacht
Co-Investments: 4
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 3
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 5
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3

What are some of recent deals done by Jeito Capital?

ReproNovo

Lausanne, Vaud, Switzerland

ReproNovo specializes in reproductive health and women's health.

BiotechnologyFertilityHealth CareLife Science
Series AMay 21, 2025
Amount Raised: $65,000,000
Azafaros

Leiden, Zuid-Holland, The Netherlands

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BMay 13, 2025
Amount Raised: $146,690,300
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Callio Therapeutics

Seattle, Washington, United States

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

BiotechnologyHealth CareMedical
Series AMar 3, 2025
Amount Raised: $187,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
XyloCor Therapeutics

King Of Prussia, Pennsylvania, United States

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2025
Amount Raised: $67,500,000
Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical
Series BDec 11, 2024
Amount Raised: $30,567,953
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
CatalYm

Planegg, Bayern, Germany

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

BiotechnologyHealth CareMedicalTherapeutics
Series DJul 16, 2024
Amount Raised: $150,000,000
HI-Bio

South San Francisco, California, United States

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

BiotechnologyLife ScienceMedicalProduct ResearchTherapeutics
Series BJan 4, 2024
Amount Raised: $95,000,000